Reports


BioEnterprise closely monitors private investment across the healthcare spectrum of biotechnology, medical device, and healthcare software & services–with a special focus on trends, financings, and opinions in the Midwest region.  Many national sources are incomplete in their reporting and documenting of Midwest healthcare investments, and therefore are unable to provide complete numbers related to deals completed and dollars invested in Midwestern states.  BioEnterprise strives to provide entrepreneurs, investors, researchers, policymakers, and the media with a fast, convenient way of staying informed of the activity in this sector with a special focus on the Midwest.

Reporters or researchers seeking more details should call or email Annette Ballou at BioEnterprise at 216.658.4525 or 
aballou@bioenterprise.com.



The BioEnterprise Monthly Healthcare Review

The Healthcare Review is a monthly survey of biotechnology, medical device, and healthcare investment activity across the globe. It summarizes venture capital and private equity investment, mergers & acquisitions, and IPO activity and provides information on each transaction and the participants.

+ Show reports



 

 

Recent News

»  VitalFlow Stimulator: New Treatment for Brain Ischemia

»  NEOMED Wins Nearly $500,000 to Drive Drug Development, Regional Economic Development

»  Juventas Tests Gene Therapy on Wounds in Phase II Trial

»  PolyOne Buys Assets, Technologies from Kraton Performance Polymers for $72 Million






CerviLenz
One of the many healthcare innovations brought to market by client companies.
» View More





Exit Companies



Since 2002, 41 Cleveland-area healthcare companies have had successful exits. 
» View More







The world’s only convention facility created for the healthcare industry.
» View More





Copyright © 2016 BioEnterprise.  | Home | Disclaimer | Sitemap | Contact UsWebsite developed by Stream 9 BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999